The Eye Foundation, founded by Dr. Ramamurthy and Dr. Chitra Ramamurthy, operates over 25 hospitals across Tamil Nadu, Kerala, and Karnataka, treating over one million patients annually. The Coimbatore-based chain specializes in a wide range of eye diseases and treatments, including cataract, retina, LASIK, glaucoma, ocular trauma, and corneal transplants, utilizing both high-tech tertiary centers and well-equipped secondary centers.
Verlinvest's investment is part of its accelerated strategy to increase its annual deployment in India's healthcare and consumer sectors, having consistently invested over $100 million annually. The partnership aims to leverage combined expertise to strengthen The Eye Foundation and bring affordable, high-quality eye care to more regions.
Veda Corporate Advisors served as the exclusive financial advisors to The Eye Foundation.
Impact: This funding is expected to significantly boost The Eye Foundation's expansion plans, potentially increasing access to quality eye care in more parts of India and strengthening its market position. It also highlights strong investor interest in India's healthcare infrastructure. Rating: 8/10.
Difficult Terms:
Clinical Excellence: The highest standard of medical care and treatment.
Gamut: The complete range or scope of something.
Tertiary Centres: Advanced healthcare facilities providing specialized medical services.
Secondary Centres: Healthcare facilities offering more specialized services than primary care but less than tertiary care.
Ocular Trauma: Injury to the eye caused by an external force.
Corneal Transplants: Surgical replacement of a damaged cornea with a healthy donor cornea.
Underserved Regions: Areas that lack adequate access to essential services like healthcare.
Patient-Centric Eye Care: Healthcare focused on the patient's needs, preferences, and values.
Accelerated India Strategy: A plan to significantly increase investment and presence in India.
Deployment: The act of putting funds to use for investment.